glp 1 and gallstones GLP-1 receptor agonists gallbladder disease risk: insights into molecular mechanisms and clinical implications GLP1-RAs and gallbladder diseases –

doi:10.2337/dci19-0066 13

J Clin Endocrinol Metab (2015) 100(4):E61622.10.1210/jc.2014-4244 98 KoutroubakisIEOustamanolakisPMalliarakiNKarmirisKChalkiadakisIGanotakisEet alEffects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease

Declining phase angle on GLP-1 therapy may signal muscle cell deterioration and trigger intervention

Quick Comparison Table The table below summarizes the major GLP-1 receptor agonists currently approved in the United States, including active ingredient, common brand names, delivery method, and labeled indications